![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
D Langin, H Paris and M Lafontan
INSERM U317, Institut de Physiologie, Universite Paul Sabatier, Toulouse, France.
Binding studies were carried out in human fat cell membranes with two alpha 2-adrenergic antagonists, [3H]idazoxan and its methoxy derivative [3H]RX821002. Inhibition studies with epinephrine enantiomers indicate that [3H]RX821002 only binds to alpha 2-adrenoceptors, whereas [3H]idazoxan labels alpha 2-adrenoceptors and additional nonadrenergic sites (NAIBS). NAIBS and alpha 2-adrenoceptors display different affinities towards drugs from various chemical families. Imidazoline and some guanidine derivatives exhibit a high affinity for NAIBS. Pharmacological studies of human NAIBS indicate that they are slightly different from those previously reported in the rabbit, suggesting the existence of several subtypes of NAIBS. Furthermore, NAIBS are different from the previously described "imidazoline-preferring sites." [3H]idazoxan and [3H]RX821002 saturation analyses were performed in human adipocytes from different anatomical locations, in order to compare the number of NAIBS and alpha 2-adrenoceptors. Although there was an important variation in NAIBS and alpha 2-adrenoceptor numbers in the studied samples, a very poor correlation was obtained between the Bmax values of the two sites. Moreover, alkylation of alpha 2- adrenoceptors by phenoxybenzamine produces a 90% reduction in accessible [3H]RX821002 binding sites, without modification of [3H]idazoxan binding. These data show that NAIBS are not closely related to the alpha 2-adrenergic molecule. In addition, benextramine appears to be a reversible competitor at NAIBS. [3H]idazoxan binding, but not [3H]RX821002 binding, is sensitive to K+, suggesting that the domains involved in the ligand-NAIBS interaction are different from those involved in the ligand-alpha 2-adrenoceptor interaction.
This article has been cited by other articles:
|
|
 |
|
  D. H. Lee, X. Liu, H. T. Kim, K. Chung, and J. M. Chung Receptor Subtype Mediating the Adrenergic Sensitivity of Pain Behavior and Ectopic Discharges in Neuropathic Lewis Rats J Neurophysiol, May 1, 1999; 81(5): 2226 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Enrique-Tarancon, L. Marti, N. Morin, J. M. Lizcano, M. Unzeta, L. Sevilla, M. Camps, M. Palacin, X. Testar, C. Carpene, et al. Role of Semicarbazide-sensitive Amine Oxidase on Glucose Transport and GLUT4 Recruitment to the Cell Surface in Adipose Cells J. Biol. Chem., April 3, 1998; 273(14): 8025 - 8032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Marti, N. Morin, G. Enrique-Tarancon, D. Prevot, M. Lafontan, X. Testar, A. Zorzano, and C. Carpéné Tyramine and Vanadate Synergistically Stimulate Glucose Transport in Rat Adipocytes by Amine Oxidase-Dependent Generation of Hydrogen Peroxide J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 342 - 349. [Abstract] [Full Text]
|
|
|
|
|
|
R. Raddatz, A. Parini, and S. M. Lanier Imidazoline/Guanidinium Binding Domains on Monoamine Oxidases J. Biol. Chem., November 17, 1995; 270(46): 27961 - 27968. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
